Zhuang G. Yang
Cancer Center And State Key Laboratory Of Biotherapy
Chengdu, 610041, China
Chengdu, 610041, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 58 publications
Design and Synthesis of USP1 Inhibitors: Synergistic Antitumor Activity with PARP Inhibitors in Triple-Negative Breast Cancer.
Journal: Journal of medicinal chemistry
Published: April 29, 2026
Rational Design of Novel pyrazolo[4,3-c]quinoline Derivatives as Potent, Selective, and Orally Bioavailable ATM Inhibitors with Promising In Vivo Efficacy.
Journal: Journal of medicinal chemistry
Published: February 11, 2026
Structure-based design and synthesis of KX-01 analogs as potent antitumor agents targeting the tubulin colchicine binding site.
Journal: European journal of medicinal chemistry
Published: February 06, 2026
Structure-based design and synthesis of 3-substituted-1,2,4-triazolo[1,5-a]pyrimidines as dual vinca/gatorbulin-site ligands for cancer treatment.
Journal: European journal of medicinal chemistry
Published: August 27, 2025
Discovery and Pharmacological Evaluation of Potent and Highly Selective PARP1 Inhibitors.
Journal: Journal of medicinal chemistry
Published: June 18, 2025
Design and Synthesis of Novel Deazapurine DNMT 1 Inhibitors with In Vivo Efficacy in DLBCL.
Journal: Journal of medicinal chemistry
Published: March 01, 2025
Synthesis of polysubstituted cyclobutanes through a photoredox strain-release/[3,3]-rearrangement cascade.
Journal: Chemical science
Published: February 22, 2025
Regiodivergent and Enantioselective Allylic C-H Alkylation of Allyl Ethers: Optimization, Scope, Mechanism and Application.
Journal: Angewandte Chemie (International ed. in English)
Published: January 02, 2025
Correction to: Preclinical studies of Flonoltinib Maleate, a novel JAK2/FLT3 inhibitor, in treatment of JAK2V617F-induced myeloproliferative neoplasms.
Journal: Blood cancer journal
Published: June 26, 2024
Discovery of Potent and Selective Phosphatidylinositol 3-Phosphate 5-Kinase (PIKfyve) Inhibitors as Methuosis Inducers.
Journal: Journal of medicinal chemistry
Published: December 20, 2023
Discovery, Optimization, and Evaluation of Potent and Selective DNA-PK Inhibitors in Combination with Chemotherapy or Radiotherapy for the Treatment of Malignancies.
Journal: Journal of medicinal chemistry
Published: December 20, 2023
Therapeutic potential of a synthetic dual JAK1/TYK2 inhibitor in inflammatory bowel disease.
Journal: International immunopharmacology
Published: June 18, 2023
Last Updated: 09/26/2026